| Name: | Candesartan Cilexetil EP Impurity H |
| Catalogue No. | VL290007 |
| CAS No. | 170791-09-0 |
| Molecular Formula | C52H48N6O6 |
| Molecular Weight | 852.97 |
| Status | In-stock |
| IUPAC Name | 2-Ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester |
| Appearance | White Solid Powder |
| Description | Candesartan Cilexetil EP Impurity H (CAS No: 170791-09-0) Or 2-Ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester,is an impurity of Candesartan Cilexetil, Candesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II, which is used for treatment of high blood pressure and congestive heart failure. |
| References | Sci-Hub | Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR | 10.1016/j.jpba.2011.05.024. (2022). Retrieved January 1, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/j.jpba.2011.05.024 |
